Hepion Pharmaceuticals, Inc. Stock price
Equities
HEPA
US4268973025
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.49 USD | -0.40% | +7.33% | -23.15% |
Mar. 06 | Hepion Pharmaceuticals, Inc. Appoints Michael Purcell to Its Board of Directors | CI |
Feb. 20 | Hepion Pharmaceuticals, Inc. Announces Board Changes | CI |
Financials (USD)
Sales 2023 * | - | Sales 2024 * | - | Capitalization | 10.8M |
---|---|---|---|---|---|
Net income 2023 * | -43M | Net income 2024 * | -51M | EV / Sales 2023 * | - |
Net cash position 2023 * | - | Net cash position 2024 * | - | EV / Sales 2024 * | - |
P/E ratio 2023 * |
-0.23
x | P/E ratio 2024 * |
-0.23
x | Employees | 25 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 99.73% |
1 day | -0.40% | ||
1 week | +7.33% | ||
Current month | -16.16% | ||
1 month | -9.78% | ||
3 months | -25.89% | ||
6 months | -48.61% | ||
Current year | -23.15% |
Managers | Title | Age | Since |
---|---|---|---|
John Cavan
CEO | Chief Executive Officer | 65 | 15-12-31 |
Daren Ure
CTO | Chief Tech/Sci/R&D Officer | - | 19-10-02 |
Chief Operating Officer | - | 22-06-13 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Brancaccio
CHM | Chairman | 76 | 13-05-14 |
Timothy Block
BRD | Director/Board Member | 69 | 13-11-25 |
Kaouthar Lbiati
BRD | Director/Board Member | 45 | 22-06-26 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 2.49 | -0.40% | 21,291 |
24-03-27 | 2.5 | +7.76% | 51,687 |
24-03-26 | 2.32 | +3.11% | 32,817 |
24-03-25 | 2.25 | -4.26% | 8,445 |
24-03-22 | 2.35 | +1.29% | 25,902 |
Delayed Quote Nasdaq, March 28, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.15% | 10.8M | |
+2.73% | 108B | |
+9.59% | 103B | |
+6.58% | 23.48B | |
-12.59% | 21.93B | |
-3.29% | 19.68B | |
-35.36% | 18.37B | |
-13.29% | 16.33B | |
+4.68% | 13.72B | |
+34.25% | 12.15B |